Immune-related adverse events with immune checkpoint blockade: a comprehensive review-Reference-Cited by-同舟云学术

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Published:2016-02 Issue: Volume:54 Page:139-148
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Michot J.M.^ORCID,Bigenwald C.,Champiat S.,Collins M.,Carbonnel F.,Postel-Vinay S.,Berdelou A.,Varga A.,Bahleda R.,Hollebecque A.,Massard C.,Fuerea A.,Ribrag V.,Gazzah A.,Armand J.P.,Amellal N.,Angevin E.,Noel N.,Boutros C.,Mateus C.,Robert C.,Soria J.C.,Marabelle A.,Lambotte O.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference79 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

3. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

4. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

5. Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy;Devaud;Oncoimmunology,2013

Cited by 1733 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy;Chinese Chemical Letters;2024-12

3. Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects;Cells;2024-09-11

4. Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review;Cardiovascular Toxicology;2024-09-10

5. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities;Cancer Immunology, Immunotherapy;2024-09-05